Journal
JOURNAL OF CLINICAL MEDICINE
Volume 11, Issue 19, Pages -Publisher
MDPI
DOI: 10.3390/jcm11195701
Keywords
drug resistance; drug tolerance; eco-evolutionary; intermittent therapy; adaptive therapy; continuous therapy; Team Medicine; intrinsically disordered proteins
Categories
Funding
- Robert and Kathleen Henderson Lung Cancer Research Accelerator Fund at the City of Hope
- William & Anna Tenenblatt Foundation
Ask authors/readers for more resources
Drug resistance is a major obstacle in cancer treatment. However, the use of a 'Team Medicine' approach and the development of new therapeutic strategies, such as intermittent therapy, based on eco-evolutionary principles, have shown promising results. Incorporating these strategies into clinical protocols can enhance the precision of personalized medicine.
Drug resistance remains one of the major impediments to treating cancer. Although many patients respond well initially, resistance to therapy typically ensues. Several confounding factors appear to contribute to this challenge. Here, we first discuss some of the challenges associated with drug resistance. We then discuss how a 'Team Medicine' approach, involving an interdisciplinary team of basic scientists working together with clinicians, has uncovered new therapeutic strategies. These strategies, referred to as intermittent or 'adaptive' therapy, which are based on eco-evolutionary principles, have met with remarkable success in potentially precluding or delaying the emergence of drug resistance in several cancers. Incorporating such treatment strategies into clinical protocols could potentially enhance the precision of delivering personalized medicine to patients. Furthermore, reaching out to patients in the network of hospitals affiliated with leading academic centers could help them benefit from such innovative treatment options. Finally, lowering the dose of the drug and its frequency (because of intermittent rather than continuous therapy) can also have a significant impact on lowering the toxicity and undesirable side effects of the drugs while lowering the financial burden carried by the patient and insurance providers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available